Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: anti-PD-(L)1-based ×

anti-PD-(L)1-based

This drug is selected. Its supporting articles are shown below.

anti-PD-(L)1-based1

Articles mentioning anti-PD-(L)1-based

1 articles · page 1 of 1

Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis

jitc · abstract · 2025-11-28 · 1 matching annotations

82.2%

Anti-PD-(L)1s anti-PD-(L)1 anti-PD-(L)1-based NSCLC Non-small cell lung cancer solid malignancies American Society of Clinical Oncology

… lung cancer (NSCLC) was the most investigated tumor (17 RCTs). Anti-PD-(L)1s performed generally worse when administered as a subsequent the…